Odysseas Kostas
Vermogen: 242 273 $ op 31-05-2026
Vermogen: 242 273 $ op 31-05-2026
Odysseas Demosthenes Kostas is currently Chairman at Amarin Corp.
Plc since 2023 and Independent Director at Armata Pharmaceuticals, Inc. since 2020.
Former positions include President & Chief Executive Officer at Essentialis, Inc., Independent Director at Enzon Pharmaceuticals, Inc. from 2013 to 2020, Director at Mast Therapeutics, Inc. from 2010 to 2011, Director at International Strategy & Investment Group LLC from 2011 to 2015, Director at International Strategy & Investment, Inc. from 2011 to 2015, Senior Managing Director at Sarissa Capital Acquisition Corp.
from 2020 to 2023, Director at Innoviva, Inc. from 2020 to 2025, Vice President-Marketing at KOS Pharmaceuticals, Inc., and Member at Yale New Haven Health Services Corp.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from The University of Texas Southwestern Medical Center.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-04-2026 | 16.720 ( 0% ) | 242 273 $ | 31-05-2026 | |
| 17-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 12-02-2020 |
| AMARIN CORPORATION PLC | Voorzitter | 27-03-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| INNOVIVA, INC. | Voorzitter | 01-12-2020 |
| SARISSA CAPITAL ACQUISITION CORP. | Corporate Officer/Principal | 13-04-2023 |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Directeur/Bestuurslid | 04-08-2020 |
International Strategy & Investment Group LLC
International Strategy & Investment Group LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur/Bestuurslid | 01-12-2015 |
International Strategy & Investment, Inc.
International Strategy & Investment, Inc. Investment ManagersFinance International Strategy & Investment (ISI) manages US fixed-income, global bond and equity-oriented funds. Their bond management is based on in-house research to anticipate interest rate changes. They actively manage portfolios to benefit from these changes. ISI manages customized US equity and balanced portfolios for high net-worth individuals. They focus on clients' specific risk tolerance, tax or other estate planning considerations. The firm's equity strategy seeks to invest in companies with competitive advantages, exceptional long-term potential and market share dominance. For institutional investors, the firm develops global investment themes across asset classes. They analyze fundamental and macroeconomic trends to provide forward-looking investment insights for sector, asset and market allocation. ISI also develops thematic and timely quantitative investment strategies for institutional equity investors. They focus on a variety of issues including topical studies, multi-factor model analysis and reviews of academic literature. ISI's quantitative research focuses on sector, industry and stock selection with special emphasis on the impact of various macro economic backgrounds. ISI on providing actionable investment ideas and proprietary research on the real estate industry and the nation's largest publicly traded real estate investment trusts (REITs).Steve has been analyzing REITs since 1993 and provides investors with a differentiated view via extensive company analysis that incorporates company visits, management meetings, field trips, and discussions with private real estate owners and commercial brokers. ISI's real estate research focuses on the real estate industry and the nation's largest publicly traded REITs across several different sectors including multi-family, retail, office, industrial and self-storage. ISI also offers detailed analysis of the technology sector. They seek to anticipate revenue growth and to identify catalysts and discontinuities that drive future growth that are unlikely to be fully discounted by the market. Their proprietary Tech Demand Model provides an early view of technology sector revenue growth, sub-sector mix and drivers. ISI's Tech Change Research employs a bottoms-up approach that anticipates change in company performance by focusing on pre-revenue and earnings drivers. ISI's technical analysis employs a unique bottom-up approach that first seeks to decipher the message from the market and interpret it into a fundamental thesis. This approach identifies underlying trends and themes before they become common knowledge in the investment community. It also serves as a check and balance to their investment theses. This affords the opportunity to cover all markets all over the world including equities, indices, fixed-income, commodities and forex. ISI's accounting and tax policy research analyzes and interprets the impact of accounting and tax issues that impact individual companies and industry sectors. This research encompasses investment themes resulting from accounting and tax policy changes, financial statement analysis, event driven corporate actions such as spin-offs and complicated structures and the quality of corporate earnings and cash flow. They also analyze financial statements and related disclosures on a customized basis. The firm offers proprietary research on the banking sector and the nation's largest bank holding companies. ISI employs bottom-up analysis that includes company visits, management meetings and differentiated financial and credit risk analysis. They focus on the largest bank holding companies, including money center, regional, trust, broker-dealer, and credit card-oriented banks. Through a joint venture with CEBM, ISI provides top-down research on China that focuses on the key trends and major events related to the Chinese economy. In addition to their macro views, they also analyze industries that are important to China's growth and the sources of many of the nation's structural issues. ISI's company surveys are a proprietary method of monitoring the economy on a weekly basis. The surveys provide timely signals on a bottoms-up basis as to the direction of the economy and inflation. In addition to company surveys, ISI also conducts sentiment and allocation surveys of hedge funds, long-only institutional equity managers and institutional bond managers. On a monthly basis, the firm conducts the state tax receipts surveys across 16 states capturing 63% of the US population. ISI also provides economic research that analyzes and forecasts global economic conditions including GDP, inflation and interest rate trends. Their publications review key economic and financial market events. ISI provides research on global integrated oil and R&M stocks and portfolio strategy views across the energy sector. They also cover major commodities in the global energy space including crude oil, natural gas and refined products. The firm's proprietary bottom-up machinery research focuses on global machinery and other industrial companies. The research incorporates differentiated fieldwork and financial analysis. The largest end markets analyzed include construction and farm equipment, on-highway trucks, industrial machine tools and related industrial components. ISI's policy research focuses on analysis of the financial market implications of policy actions and political developments. The firm publishes a daily research report covering (1) monetary, fiscal, trade and currency policy (2) issues before Congress that could affect S&P 500 sectors and (3) the outlook for and impact of elections. | Directeur/Bestuurslid | 01-12-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 13 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
International Strategy & Investment Group LLC
International Strategy & Investment Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
International Strategy & Investment, Inc.
International Strategy & Investment, Inc. Investment ManagersFinance International Strategy & Investment (ISI) manages US fixed-income, global bond and equity-oriented funds. Their bond management is based on in-house research to anticipate interest rate changes. They actively manage portfolios to benefit from these changes. ISI manages customized US equity and balanced portfolios for high net-worth individuals. They focus on clients' specific risk tolerance, tax or other estate planning considerations. The firm's equity strategy seeks to invest in companies with competitive advantages, exceptional long-term potential and market share dominance. For institutional investors, the firm develops global investment themes across asset classes. They analyze fundamental and macroeconomic trends to provide forward-looking investment insights for sector, asset and market allocation. ISI also develops thematic and timely quantitative investment strategies for institutional equity investors. They focus on a variety of issues including topical studies, multi-factor model analysis and reviews of academic literature. ISI's quantitative research focuses on sector, industry and stock selection with special emphasis on the impact of various macro economic backgrounds. ISI on providing actionable investment ideas and proprietary research on the real estate industry and the nation's largest publicly traded real estate investment trusts (REITs).Steve has been analyzing REITs since 1993 and provides investors with a differentiated view via extensive company analysis that incorporates company visits, management meetings, field trips, and discussions with private real estate owners and commercial brokers. ISI's real estate research focuses on the real estate industry and the nation's largest publicly traded REITs across several different sectors including multi-family, retail, office, industrial and self-storage. ISI also offers detailed analysis of the technology sector. They seek to anticipate revenue growth and to identify catalysts and discontinuities that drive future growth that are unlikely to be fully discounted by the market. Their proprietary Tech Demand Model provides an early view of technology sector revenue growth, sub-sector mix and drivers. ISI's Tech Change Research employs a bottoms-up approach that anticipates change in company performance by focusing on pre-revenue and earnings drivers. ISI's technical analysis employs a unique bottom-up approach that first seeks to decipher the message from the market and interpret it into a fundamental thesis. This approach identifies underlying trends and themes before they become common knowledge in the investment community. It also serves as a check and balance to their investment theses. This affords the opportunity to cover all markets all over the world including equities, indices, fixed-income, commodities and forex. ISI's accounting and tax policy research analyzes and interprets the impact of accounting and tax issues that impact individual companies and industry sectors. This research encompasses investment themes resulting from accounting and tax policy changes, financial statement analysis, event driven corporate actions such as spin-offs and complicated structures and the quality of corporate earnings and cash flow. They also analyze financial statements and related disclosures on a customized basis. The firm offers proprietary research on the banking sector and the nation's largest bank holding companies. ISI employs bottom-up analysis that includes company visits, management meetings and differentiated financial and credit risk analysis. They focus on the largest bank holding companies, including money center, regional, trust, broker-dealer, and credit card-oriented banks. Through a joint venture with CEBM, ISI provides top-down research on China that focuses on the key trends and major events related to the Chinese economy. In addition to their macro views, they also analyze industries that are important to China's growth and the sources of many of the nation's structural issues. ISI's company surveys are a proprietary method of monitoring the economy on a weekly basis. The surveys provide timely signals on a bottoms-up basis as to the direction of the economy and inflation. In addition to company surveys, ISI also conducts sentiment and allocation surveys of hedge funds, long-only institutional equity managers and institutional bond managers. On a monthly basis, the firm conducts the state tax receipts surveys across 16 states capturing 63% of the US population. ISI also provides economic research that analyzes and forecasts global economic conditions including GDP, inflation and interest rate trends. Their publications review key economic and financial market events. ISI provides research on global integrated oil and R&M stocks and portfolio strategy views across the energy sector. They also cover major commodities in the global energy space including crude oil, natural gas and refined products. The firm's proprietary bottom-up machinery research focuses on global machinery and other industrial companies. The research incorporates differentiated fieldwork and financial analysis. The largest end markets analyzed include construction and farm equipment, on-highway trucks, industrial machine tools and related industrial components. ISI's policy research focuses on analysis of the financial market implications of policy actions and political developments. The firm publishes a daily research report covering (1) monetary, fiscal, trade and currency policy (2) issues before Congress that could affect S&P 500 sectors and (3) the outlook for and impact of elections. | Finance |
Innoviva, Inc.
Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale New Haven Health Services Corp.
Yale New Haven Health Services Corp. Miscellaneous Commercial ServicesCommercial Services Provides nonprofit healthcare, primary care and neurology services | Commercial Services |
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
Sarissa Capital Acquisition Corp.
Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau